Cargando…
JAK/STAT inhibitor therapy partially rescues the lipodystrophic autoimmune phenotype in Clec16a KO mice
CLEC16A is implicated in multiple autoimmune diseases. We generated an inducible whole-body knockout (KO), Clec16a(ΔUBC) mice to address the role of CLEC16A loss of function. KO mice exhibited loss of adipose tissue and severe weight loss in response to defective autophagic flux and exaggerated endo...
Autores principales: | Pandey, Rahul, Bakay, Marina, Strenkowski, Bryan P., Hain, Heather S., Hakonarson, Hakon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016875/ https://www.ncbi.nlm.nih.gov/pubmed/33795715 http://dx.doi.org/10.1038/s41598-021-86493-8 |
Ejemplares similares
-
The Autoimmune Disorder Susceptibility Gene CLEC16A Restrains NK Cell Function in YTS NK Cell Line and Clec16a Knockout Mice
por: Pandey, Rahul, et al.
Publicado: (2019) -
CLEC16A—An Emerging Master Regulator of Autoimmunity and Neurodegeneration
por: Pandey, Rahul, et al.
Publicado: (2023) -
CLEC16A regulates splenocyte and NK cell function in part through MEK signaling
por: Pandey, Rahul, et al.
Publicado: (2018) -
SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
por: Pandey, Rahul, et al.
Publicado: (2023) -
Inducible knockout of Clec16a in mice results in sensory neurodegeneration
por: Hain, Heather S., et al.
Publicado: (2021)